These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

868 related articles for article (PubMed ID: 22901370)

  • 21. Post-stroke depression, antidepressant treatment and rehabilitation results. A case-control study.
    Paolucci S; Antonucci G; Grasso MG; Morelli D; Troisi E; Coiro P; De Angelis D; Rizzi F; Bragoni M
    Cerebrovasc Dis; 2001; 12(3):264-71. PubMed ID: 11641594
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Selective serotonin reuptake inhibitor treatment and depression are associated with poststroke mortality.
    Ried LD; Jia H; Feng H; Cameon R; Wang X; Tueth M; Wu SS
    Ann Pharmacother; 2011 Jul; 45(7-8):888-97. PubMed ID: 21750310
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacological management of post-stroke depression.
    Castilla-Guerra L; Fernandez Moreno MDC; Esparrago-Llorca G; Colmenero-Camacho MA
    Expert Rev Neurother; 2020 Feb; 20(2):157-166. PubMed ID: 31860359
    [No Abstract]   [Full Text] [Related]  

  • 24. Comparative efficacy and acceptability of antidepressant treatment in poststroke depression: a multiple-treatments meta-analysis.
    Sun Y; Liang Y; Jiao Y; Lin J; Qu H; Xu J; Zhao C
    BMJ Open; 2017 Aug; 7(8):e016499. PubMed ID: 28775189
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antidepressants for people with epilepsy and depression.
    Maguire MJ; Marson AG; Nevitt SJ
    Cochrane Database Syst Rev; 2021 Apr; 4(4):CD010682. PubMed ID: 33860531
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Safety of selective serotonin reuptake inhibitor treatment in recovering stroke patients.
    Mortensen JK; Andersen G
    Expert Opin Drug Saf; 2015 Jun; 14(6):911-9. PubMed ID: 25835753
    [TBL] [Abstract][Full Text] [Related]  

  • 27. An evaluation of efficacy and safety of reboxetine in elderly patients affected by "retarded" post-stroke depression. A random, placebo-controlled study.
    Rampello L; Alvano A; Chiechio S; Raffaele R; Vecchio I; Malaguarnera M
    Arch Gerontol Geriatr; 2005; 40(3):275-85. PubMed ID: 15814161
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Stroke and depression].
    Sivolap YP; Damulin IV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2019; 119(9):143-147. PubMed ID: 31626232
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Post-stroke depression: Chaos to exposition.
    Sarkar A; Sarmah D; Datta A; Kaur H; Jagtap P; Raut S; Shah B; Singh U; Baidya F; Bohra M; Kalia K; Borah A; Wang X; Dave KR; Yavagal DR; Bhattacharya P
    Brain Res Bull; 2021 Mar; 168():74-88. PubMed ID: 33359639
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Depression after stroke: a review of the evidence base to inform the development of an integrated care pathway. Part 2: Treatment alternatives.
    Turner-Stokes L; Hassan N
    Clin Rehabil; 2002 May; 16(3):248-60. PubMed ID: 12017512
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The influence of early depressive symptoms, social support and decreasing self-efficacy on depression 6 months post-stroke.
    Volz M; Möbus J; Letsch C; Werheid K
    J Affect Disord; 2016 Dec; 206():252-255. PubMed ID: 27513631
    [TBL] [Abstract][Full Text] [Related]  

  • 32. An updated review on prediction and preventive treatment of post-stroke depression.
    Sun S; Li Z; Xiao Q; Tan S; Hu B; Jin H
    Expert Rev Neurother; 2023; 23(8):721-739. PubMed ID: 37427452
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effectiveness of Paroxetine for Poststroke Depression: A Meta-Analysis.
    Li L; Han Z; Li L; Han L; Yan B
    J Stroke Cerebrovasc Dis; 2020 May; 29(5):104664. PubMed ID: 32093988
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Post-Stroke Depression: A Review.
    Robinson RG; Jorge RE
    Am J Psychiatry; 2016 Mar; 173(3):221-31. PubMed ID: 26684921
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A randomised controlled trial assessing the severity and duration of depressive symptoms associated with a clinically significant response to sertraline versus placebo, in people presenting to primary care with depression (PANDA trial): study protocol for a randomised controlled trial.
    Salaminios G; Duffy L; Ades A; Araya R; Button KS; Churchill R; Croudace T; Derrick C; Dixon P; Dowrick C; Gilbody S; Hollingworth W; Jones V; Kendrick T; Kessler D; Kounali D; Lanham P; Malpass A; Peters TJ; Riozzie D; Robinson J; Sharp D; Thomas L; Welton NJ; Wiles N; Lewis G
    Trials; 2017 Oct; 18(1):496. PubMed ID: 29065916
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Treatment with carotid angioplasty stent placement for post-stroke depression compared to antidepressants.
    Huang H; Chen K; Guo T; Zhang Y; Qu W; Zhou Z; Liu G; Chen L
    Neurosciences (Riyadh); 2012 Jan; 17(1):53-6. PubMed ID: 22246011
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antidepressants for people with epilepsy and depression.
    Maguire MJ; Weston J; Singh J; Marson AG
    Cochrane Database Syst Rev; 2014 Dec; 2014(12):CD010682. PubMed ID: 25464360
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Clinical effectiveness and safety of paroxetine in post-stroke depression: results from a phase 4, open label, multicenter clinical trial with 26 weeks of follow-up].
    Horváth S; Karányi Z; Harcos P; Nagy Z; Németh G; Andor G
    Orv Hetil; 2006 Dec; 147(50):2397-404. PubMed ID: 17274185
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Racial and ethnic disparities in post-stroke depression detection.
    Jia H; Chumbler NR; Wang X; Chuang HC; Damush TM; Cameon R; Williams LS
    Int J Geriatr Psychiatry; 2010 Mar; 25(3):298-304. PubMed ID: 19637399
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Management of depression in elderly stroke patients.
    Lökk J; Delbari A
    Neuropsychiatr Dis Treat; 2010 Sep; 6():539-49. PubMed ID: 20856917
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 44.